Program Information
Characterization of the Effect of a New Commercial Transmission Detector On Radiotherapy Beams
J Cheung*, O Morin , University of California San Francisco, San Francisco, CA
Presentations
SU-D-213-2 (Sunday, July 12, 2015) 2:05 PM - 3:00 PM Room: 213
Purpose: To evaluate the influence of a new commercial transmission detector on radiotherapy beams of various energies.
Methods: A transmission detector designed for online treatment monitoring was characterized on a TrueBeam STx linear accelerator with 6MV, 6FFF, 10MV, and 10FFF beams. Measurements of beam characteristics including percentage depth doses (PDDs), inplane and crossplane off-axis profiles at different depths, transmission factors, and skin dose were acquired at field sizes of 3x3cm, 5x5m, 10x10cm, and 20x20cm at 100cm and 80cm source-to-surface distance (SSD). All measurements were taken with and without the transmission detector in the path of the beam. A CC04 chamber was used for all profile and transmission factor measurements. Skin dose was assessed at 100cm, 90cm, and 80cm SSD and using a variety of detectors (Roos and Markus parallel-plate chambers, and OSLD).
Results: The PDDs showed small differences between the unperturbed and perturbed beams for both 100cm and 80cm SSD (≤4mm dmax difference and <1.2% average profile difference). The differences were larger for the flattened beams and at larger field sizes. The off-axis profiles showed similar trends. The penumbras looked similar with and without the transmission detector. Comparisons in the central 80% of the profile showed a maximum average (maximum) profile difference between all field sizes of 0.756% (1.535%) and 0.739% (3.682%) for 100cm and 80cm SSD, respectively. The average measured skin dose at 100cm (80cm) SSD for 10x10cm field size was <4% (<35%) dose increase for all energies. For 20x20cm field size, this value increased to <10% (≤45%).
Conclusion: The transmission detector has minimal effect on the clinically relevant radiotherapy beams for IMRT and VMAT (field sizes 10x10cm and less). For larger field sizes, some perturbations are observable which would need to be assessed for clinical impact.
Funding Support, Disclosures, and Conflict of Interest: The authors of this publication has research support from IBA Dosimetry.
Contact Email: